Literature DB >> 12377793

Observer variation in the diagnosis of superficial oesophageal adenocarcinoma: another spanner in the works?

D Alderson1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12377793      PMCID： PMC1773433          DOI： 10.1136/gut.51.5.620

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  10 in total

1.  Long-term follow-up of Barrett's high-grade dysplasia.

Authors:  A P Weston; P Sharma; M Topalovski; R Richards; R Cherian; A Dixon
Journal:  Am J Gastroenterol       Date:  2000-08       Impact factor: 10.864

Review 2.  Biomarkers in Barrett esophagus.

Authors:  K K Krishnadath; B J Reid; K K Wang
Journal:  Mayo Clin Proc       Date:  2001-04       Impact factor: 7.616

3.  Are ulcers a marker for invasive carcinoma in Barrett's esophagus? Data from a diagnostic variability study with clinical follow-up.

Authors:  Elizabeth Montgomery; Mary P Bronner; Joel K Greenson; Marian M Haber; John Hart; Laura W Lamps; Gregory Y Lauwers; Audrey J Lazenby; David N Lewin; Marie E Robert; Kay Washington; John R Goldblum
Journal:  Am J Gastroenterol       Date:  2002-01       Impact factor: 10.864

4.  The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.

Authors:  M Skacel; R E Petras; T L Gramlich; J E Sigel; J E Richter; J R Goldblum
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

5.  Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia.

Authors:  T G Schnell; S J Sontag; G Chejfec; G Aranha; A Metz; S O'Connell; U J Seidel; A Sonnenberg
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

6.  Observer variation in the diagnosis of superficial oesophageal adenocarcinoma.

Authors:  A H Ormsby; R E Petras; W H Henricks; T W Rice; L A Rybicki; J E Richter; J R Goldblum
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

7.  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.

Authors:  B J Reid; D S Levine; G Longton; P L Blount; P S Rabinovitch
Journal:  Am J Gastroenterol       Date:  2000-07       Impact factor: 10.864

Review 8.  High-grade dysplasia within Barrett's esophagus: controversies regarding clinical opinions and approaches.

Authors:  Mazin F Al-Kasspooles; Hank C Hill; Hector R Nava; Judy L Smith; Harold O Douglass; John F Gibbs
Journal:  Ann Surg Oncol       Date:  2002-04       Impact factor: 5.344

9.  Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation.

Authors:  E Montgomery; M P Bronner; J R Goldblum; J K Greenson; M M Haber; J Hart; L W Lamps; G Y Lauwers; A J Lazenby; D N Lewin; M E Robert; A Y Toledano; Y Shyr; K Washington
Journal:  Hum Pathol       Date:  2001-04       Impact factor: 3.466

10.  An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus.

Authors:  D S Levine; R C Haggitt; P L Blount; P S Rabinovitch; V W Rusch; B J Reid
Journal:  Gastroenterology       Date:  1993-07       Impact factor: 22.682
  10 in total
  2 in total

Review 1.  Endoscopic therapy for Barrett's oesophagus.

Authors:  H Barr; N Stone; B Rembacken
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

Review 2.  Endoscopic screening and surveillance for Barrett's esophagus--clinical implications.

Authors:  Hugh Barr; Catherine Kendall; Florain Bazant-Hegemark; Paul Moayyedi; G Shetty; Nicholas Stone
Journal:  MedGenMed       Date:  2006-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.